Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levin

Showing results (641-650 of 653) with videos related to

Pageof 66
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2023
Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung CancerCharles B Simone, Nikhil Yegya-Raman, Shwetha Manjunath, et al.
Journal of the American College of Cardiology|May 13, 2017
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further ResearchMaria Rosa Costanzo, Claudio Ronco, William T Abraham, et al.
JAMA|November 15, 2012
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomesGregory P Levin, Cassianne Robinson-Cohen, Ian H de Boer, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent ChemoradiationNikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Clinical Lung Cancer|April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health SystemNikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Pageof 66

Showing results (641-650 of 653) with videos related to

Sort By:
Pageof 66
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2023
Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung CancerCharles B Simone, Nikhil Yegya-Raman, Shwetha Manjunath, et al.
Journal of the American College of Cardiology|May 13, 2017
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further ResearchMaria Rosa Costanzo, Claudio Ronco, William T Abraham, et al.
JAMA|November 15, 2012
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomesGregory P Levin, Cassianne Robinson-Cohen, Ian H de Boer, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent ChemoradiationNikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Clinical Lung Cancer|April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health SystemNikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Pageof 66